Screening strategies based on solubility and solution composition generate pharmaceutically acceptable cocrystals of carbamazepine

被引：306

作者：

Childs, Scott L. ^{[1
]}

Rodriguez-Hornedo, Nair ^{[2
]}

Reddy, L. Sreenivas ^{[2
]}

Jayasankar, Adivaraha ^{[2
]}

Maheshwari, Chinmay ^{[2
]}

McCausland, Linda ^{[1
]}

Shipplett, Rex ^{[1
]}

Stahly, Barbara C. ^{[1
]}

机构：

[1] Inc Aptuit Co, SSCI, W Lafayette, IN 47906 USA

[2] Univ Michigan, Dept Pharmaceut Sci, Ann Arbor, MI 48109 USA

来源：

CRYSTENGCOMM | 2008年 / 10卷 / 07期

关键词：

D O I：

10.1039/b715396a

中图分类号：

O6 [化学];

学科分类号：

0703 ;

摘要：

Four different screening techniques were used to form cocrystals of carbamazepine containing pharmaceutically acceptable carboxylic acids. Twenty-seven unique solid phases utilizing eighteen carboxylic acid coformers were generated in the screening experiments. Cocrystal formation and stability in water is reported. Phase solubility diagrams and triangular phase diagrams are used to illustrate how saturation of the reactants leads to supersaturation of the cocrystal.

引用

页码：856 / 864

页数：9

共 60 条

[11] Cocrystals of piroxicam with carboxylic acids
Childs, Scott L.
Hardcastle, Kenneth I.
[J]. CRYSTAL GROWTH & DESIGN, 2007, 7 (07) : 1291 - 1304
[12] Importance of molecular shape for the overall stability of hydrogen bond motifs in the crystal structures of various carbamazepine-type drug molecules
Cruz Cabeza, Aurora J.
Day, Graeme M.
Motherwell, W. D. Samuel
Jones, William
[J]. CRYSTAL GROWTH & DESIGN, 2007, 7 (01) : 100 - 107
[13] Carbamazepine trifluoroacetic acid solvate
Fernandes, Philippe
Bardin, Julie
Johnston, Andrea
Florence, Alastair J.
Leech, Charlotte K.
David, William I. F.
Shankland, Kenneth
[J]. ACTA CRYSTALLOGRAPHICA SECTION E-STRUCTURE REPORTS ONLINE, 2007, 63 : O4269 - U2927
[14] Crystal engineering of the composition of pharmaceutical phases:: Multiple-component crystalline solids involving carbamazepine
Fleischman, SG
Kuduva, SS
McMahon, JA
Moulton, B
Walsh, RDB
Rodríguez-Hornedo, N
Zaworotko, MJ
[J]. CRYSTAL GROWTH & DESIGN, 2003, 3 (06) : 909 - 919
[15] Control and prediction of packing motifs: a rare occurrence of carbamazepine in a catemeric configuration
Florence, A. J.
Leech, C. K.
Shankland, N.
Shankland, K.
Johnston, A.
[J]. CRYSTENGCOMM, 2006, 8 (10): : 746 - 747
[16] Indexing powder patterns in physical form screening: Instrumentation and data quality
Florence, AJ
Baumgartner, B
Weston, C
Shankland, N
Kennedy, AR
Shankland, K
David, WIF
[J]. JOURNAL OF PHARMACEUTICAL SCIENCES, 2003, 92 (09) : 1930 - 1938
[17] An automated parallel crystallisation search for predicted crystal structures and packing motifs of carbamazepine
Florence, Alastair J.
Johnston, Andrea
Price, Sarah L.
Nowell, Harriott
Kennedy, Alan R.
Shankland, Norman
[J]. JOURNAL OF PHARMACEUTICAL SCIENCES, 2006, 95 (09) : 1918 - 1930
[18] Systematic investigation of the relationships between 25 crystal structures containing the carbamazepine molecule or a close analogue: a case study of the XPac method
Gelbrich, T
Hursthouse, MB
[J]. CRYSTENGCOMM, 2006, 8 (06): : 448 - 460
[19] One-solvent polymorph screen of carbamazepine
Getsoian, A.
Lodaya, R. M.
Blackburn, A. C.
[J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2008, 348 (1-2) : 3 - 9
[20] Comparison of the four anhydrous polymorphs of carbamazepine and the crystal structure of form I
Grzesiak, AL
Lang, MD
Kim, K
Matzger, AJ
[J]. JOURNAL OF PHARMACEUTICAL SCIENCES, 2003, 92 (11) : 2260 - 2271

← 1 2 3 4 5 6 →